PPT-Breast Cancer Guideline Update – Sharp Focus on Who is at Risk

Christine Lauro MD Radiation Oncologist April 21 2018 Outline Epidemiology Breast Cancer Risk FactorsSymptoms Benefits of Screening Review of Guidelines Epidemiology Epidemiology The chance of developing an invasive breast cancer at some time in a womans life is about 1 in 8 12. nbcamorg reast cancer is the second most common kind of cancer in women About 1 in 8 women born today in the United States will get breast cancer at some point The good news is that many women can survive breast cancer if its found and treated earl Changing Philosophies in Educating Women and Teens . Courtney Benedict CNM MSN. Disclosures. Merck Nexplanon trainer . Session Objectives. Explain the rationale for initiation and frequency of clinical breast exams to clients. Kristin . DePrince. Mattie, M.S.. Licensed / Certified Genetic Counselor. William G. Rohrer Cancer Genetics Program. Objectives. Describe . current approaches to genetic testing for hereditary cancer syndromes. Susan M. Domchek, MD. Basser Professor of Oncology. University of Pennsylvania . Sex. Age. Family . history. Depends on specific of family history. Depends on whether there is a k. nown . genetic . susceptibility. Dr. Ruth . Heisey. Family Physician/GP Oncologist. Women’s College Hospital/Princess Margaret . Cancer Centre. Clinician Investigator/Associate Professor. University of Toronto. Sandy Fawcett . RN(EC) NP-Adult. For Fellows November 2016. American Cancer Society, 2015 Statistics. Risk Factors. Female. Age: median 57-62. Family history. Previous biopsies. Atypical changes. BRCA positive. Hormone replacement. Alcohol use. Changing Philosophies in Educating Women and Teens . Courtney Benedict CNM MSN. Disclosures. Merck Nexplanon trainer . Session Objectives. Explain the rationale for initiation and frequency of clinical breast exams to clients. Rachna Raman MD MS. Hematology and Medical Oncology. Bon Secours Cancer Institute at St. Mary’s Hospital. Objectives. Risk factors . Screening guidelines and controversies. Screening and management of patients at high risk for breast cancer. BRCA1 and BRCA2. Jennifer . Hardee. Normal function of the genes. BRCA1 & BRCA2 are in the same DNA repair pathway. Despite names, do not share any protein structure. Both are . tumor suppressors . Audience. : . GenEd. Biology . students. Linda Grisham, Massachusetts Bay Community College. Mark Maloney, Spelman College. Kim . Gernert. , Emory University . Inspired by the recent Angelina Jolie health . Most of these lesions are benign. Breast cancer is 2. nd. most common cause of cancer deaths in women, following. carcinoma of the lung. . The clinical significance of the . benign. conditions:. 1- possible clinical confusion with malignancy. and the . Environment. Note: You will need to provide water and paper towels for participants.. Breast . Cancer Risk: . Genes . and the Environment. . Please complete the “Participant Card”. 3. Azeez Farooki, MD. Attending Physician, Clinical Member. Memorial Sloan Kettering Cancer Center. New York, NY. Objectives. Elucidate the problem of aromatase inhibitor induced bone loss and increased risk of fractures in breast cancer. Pragya Kumari. 1. , . Atanu. Bhattacharjee. 2. , Gajendra K. Vishwakarma. 1. 1. Indian Institute of Technology (ISM) Dhanbad, India, 826004. 2. Institute of . Acturial. . Sceience. and Data Analytics, UCSI University, Malaysia, 56000.